Brief: Foghorn Therapeutics Q2 EPS USD -0.45
08/08/2024 12:00
Aug 08 (Reuters) - Foghorn Therapeutics Q2 collaboration revenue USD 6.888 million. * Q2 net income USD -22.979 million
FHTX — Foghorn Therapeutics News Story
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m